
Gabriel Tremblay, DBA, Founder & CEO, Untraceable
Doctorate in business administration (DBA), specialising in decision-making; researcher in health economics and outcomes research.
I was a global director of health economics inside pharma, running a small team with exactly this problem. Then a vice president at a CRO for five years, on the receiving end of sponsor data and subcontracting work out.
I have sat on all three sides of this transaction, the sponsor, the vendor, and now the tooling. Untraceable is the thing I wanted in the first two seats and could not buy.
The same argument, addressed to the sponsor side of the table, runs through the pharma teams page. What the company has actually measured and published is on the benchmark.
The claims this company makes about cloaking are measured and published, with the DOIs attached, so anyone can check them rather than take our word for it.
Poster · Zenodo preprint · 2026-07-14 · doi:10.5281/zenodo.21343321
Editorial · Zenodo preprint · 2026-07-14 · doi:10.5281/zenodo.21343422
Editorial · Zenodo preprint · 2026-07-14 · doi:10.5281/zenodo.21343394
Poster · Zenodo preprint · 2026-07-14 · doi:10.5281/zenodo.21343363
Poster · Zenodo preprint · 2026-07-14 · doi:10.5281/zenodo.21343186
Those are the papers behind this product. His wider peer-reviewed work in health economics and outcomes research, which has nothing to do with cloaking, is on his ResearchGate profile.
All publications →